Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,244,957
+$96,252 QoQ
Shares Held
8,961
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,030
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. AMGN ranks #3 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
This page
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,244,957 | 8,961 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,148,705 | 8,949 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,064,930 | 9,364 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,119,438 | 11,054 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,112,912 | 11,149 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,381,639 | 14,064 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,685,449 | 14,140 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,588,270 | 14,240 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,452,412 | 14,250 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,079,992 | 14,350 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,076,923 | 14,155 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,804,297 | 14,155 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,270,354 | 14,730 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,544,538 | 14,662 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,892,587 | 14,821 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,385,733 | 15,021 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,796,209 | 15,603 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,745,549 | 15,489 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,738,768 | 21,064 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,993,327 | 28,184 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $6,913,237 | 28,362 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $7,124,425 | 28,634 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,123,841 | 30,984 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $7,859,898 | 30,925 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $25,785,394 | 109,325 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $24,161,361 | 119,180 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||